Lannett Company Overview
- Founded
-
1942
- Status
-
Public
- Employees
-
564
- Stock Symbol
-
LCI
- Investments
-
5
- Share Price
-
$1.64
- (As of Monday Closing)
Lannett Company General Information
Description
Lannett Co Inc develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products. It offers solid oral, extended-release, topical, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, patch, foam, buccal, sublingual, soft gel, and injectable dosages. In addition, the company also provides its products for various medical indications comprising glaucoma, gastrointestinal, migraine, obesity, respiratory, and others. It operates in the segment of generic pharmaceuticals. Its customers include generic pharmaceutical distributors, drug wholesalers, chain drug stores, private label distributors, mail-order pharmacies, and others.
Contact Information
Primary Industry
Pharmaceuticals
Stock Exchange
NYS
Primary Office
- 1150 Northbrook Drive
- Suite 155
- Trevose, PA 19053
- United States
+1 (215) 000-0000
Lannett Company Stock Performance
(As of Monday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $1.64 | $1.59 | $1.54 - $3.72 | $17.1M | 10.8M | 75.6K | -$18.92 |
Lannett Company Financials Summary
|
In Thousands, USD |
TTM 31-Dec-2022 | FY 2022 30-Jun-2022 | FY 2021 30-Jun-2021 | FY 2020 30-Jun-2020 |
|---|---|---|---|---|
| EV | 575,072 | 541,283 | 736,307 | 897,343 |
| Revenue | 308,519 | 340,579 | 478,778 | 545,744 |
| EBITDA | (105,896) | (141,678) | (201,196) | 74,526 |
| Net Income | (192,520) | (231,620) | (363,475) | (33,366) |
| Total Assets | 438,359 | 484,435 | 683,737 | 1,136,555 |
| Total Debt | 635,370 | 627,006 | 603,775 | 692,070 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Lannett Company Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Lannett Company Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Lannett Co Inc develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical produ
Pharmaceuticals
Trevose, PA
564
As of 2022
000000000
000 00
o laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in repr
000000000000000
Milan, Italy
000
As of 0000
000000000000
000000
lit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidat
000000000000000
Chicago, IL
000
As of 0000
00000
0000
0000-00-00
000000&0
00000
Add Comparison
Lannett Company Competitors (25)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Doc Generici | Private Equity-Backed | Milan, Italy | 000 | 000000000000 | ||
| 000000 00000000000 | Corporate Backed or Acquired | Chicago, IL | 000 | 00000 | 000000&0 | 00000 |
| 000000000000000 00 | Corporation | Lagos, Nigeria | 00 | |||
| 000000 00000000000 | Corporation | Piscataway, NJ | 000 | 000000000 - | ||
| 000000 00000000000 | Private Equity-Backed | East Brunswick, NJ | 000 | 00000000000 |
Lannett Company Patents
Lannett Company Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20160030723-A1 | Multi-chamber anesthetic delivery system | Inactive | 15-Mar-2013 | 0000000000 | |
| US-20090148512-A1 | Novel uses of chloramphenicol and analogous thereof | Inactive | 07-Dec-2007 | 0000000000 | 0 |
Lannett Company Executive Team (12)
Lannett Company Board Members (7)
| Name | Representing | Role | Since |
|---|---|---|---|
| 00000 000000 | Lannett Company | Board Member | 000 0000 |
| 0000000 000000 | Lannett Company | Board Member | 000 0000 |
| 0000 0000000 | Lannett Company | Board Member | 000 0000 |
| 0000000 0000000000 | Lannett Company | Board Member | 000 0000 |
| 0000000 000000 | Self | Chairman & Board Member | 000 0000 |
Lannett Company Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Lannett Company Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Lannett Company Investments & Acquisitions (5)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 0000 00000000 | 07-May-2018 | 000000000 | 0000 | Buildings and Property | 0000000 0 |
| 0000000 00000 | 25-Nov-2015 | 0000000000 | 00.000 | Pharmaceuticals | 000000 00 |
| 000000 000000 | 01-Jun-2015 | 0000000000 | 000.00 | Pharmaceuticals | 000000 00 |
| 0000000 00000 | 20-Aug-2014 | 0000000000 | Pharmaceuticals | 000000 00 | |
| Cody Laboratories | 10-Apr-2007 | Merger/Acquisition | Pharmaceuticals | 000000 00 |
Lannett Company Subsidiaries (1)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| 0000000 0000000 (0 | Other Pharmaceuticals and Biotechnology | Carmel, NY |
Lannett Company ESG
Risk Overview
Risk Rating
Updated December, 14, 2022
30.65 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
00.00
Management
Management is related to actions taken to manage ESG issues
00.00
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
00 of 15,231
Rank
00.0
Percentile
Pharmaceuticals
Industry
00 of 899
Rank
00.00
Percentile
Pharmaceuticals
Subindustry
00 of 431
Rank
00.00
Percentile
Lannett Company Exits (1)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| 0000 000000000000 | 10-Apr-2007 | 000000000000000000 | Completed |
|